US Stock MarketDetailed Quotes

XLO Xilio Therapeutics

Watchlist
  • 1.050
  • -0.050-4.55%
Close Apr 23 16:00 ET
  • 1.110
  • +0.060+5.71%
Post 19:46 ET
36.20MMarket Cap-377P/E (TTM)

Xilio Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-11.24%79.13M
-21.74%18.13M
-14.08%17.36M
-18.07%20.12M
10.85%23.53M
18.80%89.15M
18.46%23.17M
26.60%20.21M
6.72%24.55M
28.47%21.22M
Selling and administrative expenses
-9.85%27M
-21.74%6.39M
-11.97%6.31M
-16.95%6.9M
17.31%7.4M
25.54%29.95M
-0.41%8.17M
30.54%7.17M
57.85%8.31M
28.68%6.3M
-General and administrative expense
-9.85%27M
-21.74%6.39M
-11.97%6.31M
-16.95%6.9M
17.31%7.4M
25.54%29.95M
-0.41%8.17M
30.54%7.17M
57.85%8.31M
28.68%6.3M
Research and development costs
-11.93%52.14M
-21.74%11.74M
-15.24%11.05M
-18.64%13.22M
8.12%16.13M
15.65%59.2M
32.11%15M
24.53%13.04M
-8.45%16.25M
28.39%14.92M
Operating profit
11.24%-79.13M
21.74%-18.13M
14.08%-17.36M
18.07%-20.12M
-10.85%-23.53M
-18.80%-89.15M
-18.46%-23.17M
-26.60%-20.21M
-6.72%-24.55M
-28.47%-21.22M
Net non-operating interest income expense
Other net income (expense)
194.39%2.73M
-32.24%475K
47.36%613K
1,347.54%761K
782.17%880K
222.62%927K
583.45%701K
243.45%416K
64.94%-61K
12.24%-129K
Other non- operating income (expenses)
194.39%2.73M
-32.24%475K
47.36%613K
1,347.54%761K
782.17%880K
222.62%927K
583.45%701K
243.45%416K
64.94%-61K
12.24%-129K
Income before tax
13.40%-76.4M
21.41%-17.66M
15.37%-16.75M
21.36%-19.36M
-6.06%-22.65M
-16.39%-88.22M
-14.03%-22.47M
-21.78%-19.79M
-6.18%-24.61M
-28.12%-21.35M
Income tax
Net income
13.40%-76.4M
21.41%-17.66M
15.37%-16.75M
21.36%-19.36M
-6.06%-22.65M
-16.39%-88.22M
-14.03%-22.47M
-21.78%-19.79M
-6.18%-24.61M
-28.12%-21.35M
Net income continuous Operations
13.40%-76.4M
21.41%-17.66M
15.37%-16.75M
21.36%-19.36M
-6.06%-22.65M
-16.39%-88.22M
-14.03%-22.47M
-21.78%-19.79M
-6.18%-24.61M
-28.12%-21.35M
Minority interest income
Net income attributable to the parent company
13.40%-76.4M
21.41%-17.66M
15.37%-16.75M
21.36%-19.36M
-6.06%-22.65M
-16.39%-88.22M
-14.03%-22.47M
-21.78%-19.79M
-6.18%-24.61M
-28.12%-21.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
13.40%-76.4M
21.41%-17.66M
15.37%-16.75M
21.36%-19.36M
-6.06%-22.65M
-16.39%-88.22M
-14.03%-22.47M
-21.78%-19.79M
-6.18%-24.61M
-28.12%-21.35M
Basic earnings per share
13.66%-2.78
21.95%-0.64
15.28%-0.61
22.22%-0.7
-6.41%-0.83
76.18%-3.22
16.33%-0.82
-18.14%-0.72
-3.53%-0.9
-24.79%-0.78
Diluted earnings per share
13.66%-2.78
21.95%-0.64
15.28%-0.61
22.22%-0.7
-6.41%-0.83
76.18%-3.22
16.33%-0.82
-18.14%-0.72
-3.53%-0.9
-24.79%-0.78
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -11.24%79.13M-21.74%18.13M-14.08%17.36M-18.07%20.12M10.85%23.53M18.80%89.15M18.46%23.17M26.60%20.21M6.72%24.55M28.47%21.22M
Selling and administrative expenses -9.85%27M-21.74%6.39M-11.97%6.31M-16.95%6.9M17.31%7.4M25.54%29.95M-0.41%8.17M30.54%7.17M57.85%8.31M28.68%6.3M
-General and administrative expense -9.85%27M-21.74%6.39M-11.97%6.31M-16.95%6.9M17.31%7.4M25.54%29.95M-0.41%8.17M30.54%7.17M57.85%8.31M28.68%6.3M
Research and development costs -11.93%52.14M-21.74%11.74M-15.24%11.05M-18.64%13.22M8.12%16.13M15.65%59.2M32.11%15M24.53%13.04M-8.45%16.25M28.39%14.92M
Operating profit 11.24%-79.13M21.74%-18.13M14.08%-17.36M18.07%-20.12M-10.85%-23.53M-18.80%-89.15M-18.46%-23.17M-26.60%-20.21M-6.72%-24.55M-28.47%-21.22M
Net non-operating interest income expense
Other net income (expense) 194.39%2.73M-32.24%475K47.36%613K1,347.54%761K782.17%880K222.62%927K583.45%701K243.45%416K64.94%-61K12.24%-129K
Other non- operating income (expenses) 194.39%2.73M-32.24%475K47.36%613K1,347.54%761K782.17%880K222.62%927K583.45%701K243.45%416K64.94%-61K12.24%-129K
Income before tax 13.40%-76.4M21.41%-17.66M15.37%-16.75M21.36%-19.36M-6.06%-22.65M-16.39%-88.22M-14.03%-22.47M-21.78%-19.79M-6.18%-24.61M-28.12%-21.35M
Income tax
Net income 13.40%-76.4M21.41%-17.66M15.37%-16.75M21.36%-19.36M-6.06%-22.65M-16.39%-88.22M-14.03%-22.47M-21.78%-19.79M-6.18%-24.61M-28.12%-21.35M
Net income continuous Operations 13.40%-76.4M21.41%-17.66M15.37%-16.75M21.36%-19.36M-6.06%-22.65M-16.39%-88.22M-14.03%-22.47M-21.78%-19.79M-6.18%-24.61M-28.12%-21.35M
Minority interest income
Net income attributable to the parent company 13.40%-76.4M21.41%-17.66M15.37%-16.75M21.36%-19.36M-6.06%-22.65M-16.39%-88.22M-14.03%-22.47M-21.78%-19.79M-6.18%-24.61M-28.12%-21.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 13.40%-76.4M21.41%-17.66M15.37%-16.75M21.36%-19.36M-6.06%-22.65M-16.39%-88.22M-14.03%-22.47M-21.78%-19.79M-6.18%-24.61M-28.12%-21.35M
Basic earnings per share 13.66%-2.7821.95%-0.6415.28%-0.6122.22%-0.7-6.41%-0.8376.18%-3.2216.33%-0.82-18.14%-0.72-3.53%-0.9-24.79%-0.78
Diluted earnings per share 13.66%-2.7821.95%-0.6415.28%-0.6122.22%-0.7-6.41%-0.8376.18%-3.2216.33%-0.82-18.14%-0.72-3.53%-0.9-24.79%-0.78
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg